FDA Adverse Event Injury Summary report: N

UNKNOWN COOLSCULPTING SYSTEM

MDR report key: 18489222 · Received January 10, 2024

Report

Report Number
3007215625-2024-00037
Event Type
Injury
Date Received
January 10, 2024
Report Date
January 10, 2024
Manufacturer
ALLERGAN PLEASANTON
Product Code
OOK
PMA / PMN Number
K160259
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

PARADOXICAL ADIPOSE HYPERPLASIA (PH/PAH) IS A KNOWN POTENTIAL ADVERSE EVENT ADDRESSED IN THE PRODUCT LABELING. ACCORDING TO THE COOLSCULPTING USER MANUAL, UNDER RARE ADVERSE EVENTS, PARADOXICAL ADIPOSE HYPERPLASIA (PH/PAH) IS CHARACTERIZED BY A VISIBLY ENLARGED TISSUE VOLUME WITHIN THE TREATMENT AREA, WHICH MAY DEVELOP TWO TO FIVE MONTHS AFTER TREATMENT. SURGICAL INTERVENTION MAY BE REQUIRED. PAH IS NOT RELATED TO ANY COOLSCULPTING DEVICE FAILURE MODE BUT IT IS INCLUDED IN THE RISK MANAGEMENT FILES OF THE DEVICE BECAUSE IT IS A RISK THAT IS INHERENT TO THE USE CRYOLIPOLYSIS FOR LOCALIZED FAT REDUCTION. A SUPPLEMENTAL REPORT WILL BE SUBMITTED IF AND WHEN ADDITIONAL INFORMATION IS OBTAINED.

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION: ADDITIONAL AREA DESIGNATED FLANKS TO THE ABDOMEN (PREVIOUS DOCUMENTED).

Description of Event or Problem · 0

ALLERGAN AESTHETICS RECEIVED A REPORT FROM A FEMALE PATIENT WHO RECEIVED COOLSCULPTING TREATMENT TO THE THIGHS ON (B)(6) 2015 AND DEVELOPED PARADOXICAL ADIPOSE HYPERPLASIA (PAH/PH) TO THE OUTER THIGHS AFTER TREATMENT. THE INNER THIGHS WERE ADDRESSED IN A PRIOR REPORT. IN ADDITION, THE PATIENT INDICATED THAT THE ABDOMEN, ARMS, AND SUBMENTAL AREA HAD THE POSSIBLE PARADOXICAL ADIPOSE HYPERPLASIA (PAH/PH) DEVELOPMENT [PATIENT DID NOT PROVIDE OBJECTIVE EVIDENCE OF COOLSCULPTING DEVICE USE IN THOSE AREAS]. [ PRIOR MDR REPORT: REPORT REF#: 3007215625-2022-01424-02 / MFR#: 3007215625-2022-01424 FOLLOW-UP # 2].

Description of Event or Problem · 0

ALLERGAN AESTHETICS RECEIVED A REPORT FROM A FEMALE PATIENT WHO RECEIVED COOLSCULPTING TREATMENT TO THE THIGHS ON 04-JUNE-2015 AND DEVELOPED PARADOXICAL ADIPOSE HYPERPLASIA (PAH/PH) TO THE OUTER THIGHS AFTER TREATMENT. THE INNER THIGHS WERE ADDRESSED IN A PRIOR REPORT. IN ADDITION, THE PATIENT INDICATED THAT THE ABDOMEN, ARMS, AND SUBMENTAL AREA HAD THE POSSIBLE PARADOXICAL ADIPOSE HYPERPLASIA (PAH/PH) DEVELOPMENT [PATIENT DID NOT PROVIDE OBJECTIVE EVIDENCE OF COOLSCULPTING DEVICE USE IN THOSE AREAS]. [ PRIOR MDR REPORT: REPORT REF # 3007215625-2022-01424-02 / MFR # 3007215625-2022-01424 FOLLOW-UP # 2 ].

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
888095 UNKNOWN COOLSCULPTING SYSTEM DERMAL COOLING PACK/VACUUM/MASSAGER OOK ALLERGAN PLEASANTON NI

Patients

Seq Age Sex Outcome Treatment
1 Female Required Intervention